Whole Exome Sequencing Data of Dabrafenib Resistant HT-29 Cell Line

ChEBI2023-09-06 更新2026-07-12 收录

癌症耐药性

靶点突变分析

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-MTAB-13338 数据链接链接失效反馈

官方服务：

资源简介：

Whole Exome Sequencing Data of Dabrafenib Resistant HT-29 Cell Line

创建时间：

2023-09-06

Single-cell lineage analysis reveals genetic and epigenetic interplay in glioblastoma drug resistance

单细胞分析

癌症耐药性

Drug resistance is a central problem in cancer therapy, yet the underlying mechanisms remain obscure. Cancer cells typically acquire resistance via genetic mutations, but may also adopt reversible epi

干细胞与再生医学数据中心2022-02-20 更新120

DataSheet_1_Differential Mutation Detection Capability Through Capture-Based Targeted Sequencing in Plasma Samples in Hepatocellular Carcinoma.pdf

ctDNA检测

靶点突变分析

Circulating tumor DNA (ctDNA) is a promising biomarker for accurate monitoring and less invasive assessment of tumor burden and treatment response. Here, targeted next-generation sequencing (NGS) with

NIAID Data Ecosystem40

Research of miRNA193 in exosomes in esophageal cancer cells

microRNA

癌症耐药性

Screening miRNAs with differential expressions in cisplatin-resistant exosomes by Small RNA-Seq and RNA-seq.

NIAID Data Ecosystem40

Lentiviral-driven discovery of cancer drug resistance mutations. Lentiviral-driven discovery of cancer drug resistance mutations

癌症耐药性

基因突变

Identifying resistance mutations in a drug target provides crucial information. Lentiviral transduction creates multiple types of mutations due to the error-prone nature of the HIV-1 reverse transcrip

NIAID Data Ecosystem90

MOESM2 of Apatinib preferentially inhibits PC9 gefitinib-resistant cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway

癌症耐药性

靶向治疗药物

Additional file 2. Differentially expressed genes in PC9GR cells after treatment with apatinib.

Figshare2019-05-02 更新40